Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 7,7-dimethyl-2-oxo-, (1S)- → (6-Bromo-imidazo[1,2-a]pyrazin-8-yl)-[4-(1-methyl-piperidin-4-yl)-phenyl]-amine
Reaktionsgleichung
[Br:1][C:2]1[N:3]=[C:4](Br)[C:5]2[N:6]([CH:8]=[CH:9][N:10]=2)[CH:7]=1.[CH3:12][N:13]1[CH2:18][CH2:17][CH:16]([C:19]2[CH:24]=[CH:23][C:22]([NH2:25])=[CH:21][CH:20]=2)[CH2:15][CH2:14]1.CC1(C)C2(CS(O)(=O)=O)C(CC1CC2)=O>CC(O)C>[Br:1][C:2]1[N:3]=[C:4]([NH:25][C:22]2[CH:23]=[CH:24][C:19]([CH:16]3[CH2:15][CH2:14][N:13]([CH3:12])[CH2:18][CH2:17]3)=[CH:20][CH:21]=2)[C:5]2[N:6]([CH:8]=[CH:9][N:10]=2)[CH:7]=1Komponenten
5
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
A solution of 6,8-dibromoimidazo[1,2-a]pyrazine (500 mg, 1.8 mmol), 4-(1-methylpiperidin-4-yl)benzenamine (376 mg, 1.98 mmol) and CSA (356 mg, 1.53 mmol) in iPrOH (30 mL) was stirred at 90° C. overnight. The solvent was evaporated. The residue was dissolved in DCM (30 mL), NaHCO3 solution (10 mL) was added to adjust pH=8. The organic layer was dried over Na2SO4 and evaporated. The residue was purified through a silica-gel column (ethyl acetate:petroleum ether=1:1) to afford the desired product as a yellow solid (400 mg, 58% yield).
Aufarbeitung
- customThe solvent was evaporated
- dissolutionThe residue was dissolved in DCM (30 mL)
- additionNaHCO3 solution (10 mL) was added
- dry with materialThe organic layer was dried over Na2SO4
- customevaporated
- customThe residue was purified through a silica-gel column (ethyl acetate:petroleum ether=1:1)
Quellen und Nachweise
- ORD-Eintrag
- ord-01965b3274434ea4b74cf8545607539d
- Quelldatensatz
- uspto-grants-2014_06
- Patentnummer
- US08742098B2
Notizen zur Reaktion
Wird geladen…